Log In
BCIQ
Print this Print this
 

DCtag-CEA

  Manage Alerts
Collapse Summary General Information
Company PX Biosolutions Pty. Ltd.
DescriptionNanoparticle acting as an adjuvant coupled to carcinoembryonic antigen (CEA)
Molecular Target Carcinoembryonic antigen (CEA)
Mechanism of ActionAdjuvant
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCervical cancer
Indication DetailsTreat cervical cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/14/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today